192 related articles for article (PubMed ID: 8387578)
1. Primary Ki-1 anaplastic large-cell lymphoma in adults: clinical characteristics and therapeutic outcome.
Shulman LN; Frisard B; Antin JH; Wheeler C; Pinkus G; Magauran N; Mauch P; Nobles E; Mashal R; Canellos G
J Clin Oncol; 1993 May; 11(5):937-42. PubMed ID: 8387578
[TBL] [Abstract][Full Text] [Related]
2. Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphoma.
Greer JP; Kinney MC; Collins RD; Salhany KE; Wolff SN; Hainsworth JD; Flexner JM; Stein RS
J Clin Oncol; 1991 Apr; 9(4):539-47. PubMed ID: 1648596
[TBL] [Abstract][Full Text] [Related]
3. [Anaplastic large cell lymphoma based on our clinicopathological cases].
Iványi JL; Marton E; Szabó F; Mahunka M; Kelényi G
Orv Hetil; 1997 Mar; 138(13):779-84. PubMed ID: 9173373
[TBL] [Abstract][Full Text] [Related]
4. A small-cell-predominant variant of primary Ki-1 (CD30)+ T-cell lymphoma.
Kinney MC; Collins RD; Greer JP; Whitlock JA; Sioutos N; Kadin ME
Am J Surg Pathol; 1993 Sep; 17(9):859-68. PubMed ID: 8394652
[TBL] [Abstract][Full Text] [Related]
5. Follicular large-cell lymphoma treated with intensive chemotherapy: an analysis of 89 cases included in the LNH87 trial and comparison with the outcome of diffuse large B-cell lymphoma. Groupe d'Etude des Lymphomes de l'Adulte.
Wendum D; Sebban C; Gaulard P; Coiffier B; Tilly H; Cazals D; Boehn A; Casasnovas RO; Bouabdallah R; Jaubert J; Ferrant A; Diebold J; de Mascarel A; Gisselbrecht C
J Clin Oncol; 1997 Apr; 15(4):1654-63. PubMed ID: 9193366
[TBL] [Abstract][Full Text] [Related]
6. Anaplastic large cell lymphoma (Ki-1+/CD30+) in childhood.
Vecchi V; Burnelli R; Pileri S; Rosito P; Sabattini E; Civino A; Pericoli R; Paolucci G
Med Pediatr Oncol; 1993; 21(6):402-10. PubMed ID: 8390600
[TBL] [Abstract][Full Text] [Related]
7. CD30/Ki-1-positive anaplastic large cell lymphoma preceded by Hodgkin's disease.
Tsurumi H; Takahashi T; Moriwaki H; Muto Y
Int J Hematol; 1992 Aug; 56(1):99-102. PubMed ID: 1327272
[TBL] [Abstract][Full Text] [Related]
8. Peripheral T-cell lymphoma in childhood and adolescence. A clinicopathologic study of 22 patients.
Gordon BG; Weisenburger DD; Warkentin PI; Anderson J; Sanger WG; Bast M; Gnarra D; Vose JM; Bierman PJ; Armitage JO
Cancer; 1993 Jan; 71(1):257-63. PubMed ID: 8380117
[TBL] [Abstract][Full Text] [Related]
9. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
10. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
11. Diffuse large-cell lymphoma of the testis.
Tondini C; Ferreri AJ; Siracusano L; Valagussa P; Giardini R; Rampinelli I; Bonadonna G
J Clin Oncol; 1999 Sep; 17(9):2854-8. PubMed ID: 10561362
[TBL] [Abstract][Full Text] [Related]
12. B-cell lineage confers a favorable outcome among children and adolescents with large-cell lymphoma: a Pediatric Oncology Group study.
Hutchison RE; Berard CW; Shuster JJ; Link MP; Pick TE; Murphy SB
J Clin Oncol; 1995 Aug; 13(8):2023-32. PubMed ID: 7636544
[TBL] [Abstract][Full Text] [Related]
13. Late relapse in patients with diffuse large-cell lymphoma treated with MACOP-B.
Lee AY; Connors JM; Klimo P; O'Reilly SE; Gascoyne RD
J Clin Oncol; 1997 May; 15(5):1745-53. PubMed ID: 9164181
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous presentation on the eyelid of primary, systemic, CD30+, anaplastic lymphoma kinase (ALK)-negative, anaplastic large-cell lymphoma (ALCL).
Mencía-Gutiérrez E; Gutiérrez-Díaz E; Salamanca J; Martínez-González MA
Int J Dermatol; 2006 Jun; 45(6):766-9. PubMed ID: 16796648
[TBL] [Abstract][Full Text] [Related]
15. Prognostic features and outcome in patients with diffuse large B-cell lymphoma who do not achieve a complete response to first-line regimens.
Villela L; López-Guillermo A; Montoto S; Rives S; Bosch F; Perales M; Ferrer A; Esteve J; Colomo L; Campo E; Montserrat E
Cancer; 2001 Apr; 91(8):1557-62. PubMed ID: 11301405
[TBL] [Abstract][Full Text] [Related]
16. Clinical implications of serum levels of soluble CD30 in 70 adult anaplastic large-cell lymphoma patients.
Zinzani PL; Pileri S; Bendandi M; Buzzi M; Sabattini E; Ascani S; Gherlinzoni F; Magagnoli M; Albertini P; Tura S
J Clin Oncol; 1998 Apr; 16(4):1532-7. PubMed ID: 9552063
[TBL] [Abstract][Full Text] [Related]
17. Non-Hodgkin's lymphoma of the paranasal sinuses: clinical and pathological features, and response to combined-modality therapy.
Hausdorff J; Davis E; Long G; Hoppe R; van der Pas M; Lassman C; Kamel O; Jacobs C
Cancer J Sci Am; 1997; 3(5):303-11. PubMed ID: 9327155
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of the efficacy of CCCG-97 and BFM-90 protocols in the treatment for children with mature B-cell non-Hodgkin's lymphoma].
Meng JH; Gao YJ; Lu FJ; Zhai XW; Wang HS; Li J
Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):222-7. PubMed ID: 22780979
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of p80 and visceral involvement in childhood CD30 anaplastic large cell lymphoma (ALCL).
Massimino M; Spreafico F; Luksch R; Giardini R
Med Pediatr Oncol; 2001 Aug; 37(2):97-102. PubMed ID: 11496346
[TBL] [Abstract][Full Text] [Related]
20. Primary cutaneous CD30-positive large cell lymphoma: definition of a new type of cutaneous lymphoma with a favorable prognosis. A European Multicenter Study of 47 patients.
Beljaards RC; Kaudewitz P; Berti E; Gianotti R; Neumann C; Rosso R; Paulli M; Meijer CJ; Willemze R
Cancer; 1993 Mar; 71(6):2097-104. PubMed ID: 8382999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
